Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy

Area of Science:

• Neuroscience
• Metabolic Disorders
• Pharmacology

Background:

• Lipodystrophy (LD) is a rare disorder characterized by loss of adipose tissue.
• Metreleptin treatment for LD offers insights into leptin's role in metabolism and appetite regulation.
• Previous functional MRI (fMRI) studies indicated increased brain connectivity in the hypothalamus of LD patients on metreleptin.

Purpose of the Study:

• To replicate fMRI findings on brain connectivity changes in LD patients treated with metreleptin.
• To compare brain connectivity alterations between LD patients on metreleptin and healthy controls.
• To investigate the long-term effects of metreleptin on brain networks.

Main Methods:

• Resting-state functional MRI (fMRI) was used to measure brain connectivity.
• Eigenvector centrality was computed from fMRI data in 4 female LD patients and 3 healthy controls over 12 weeks.
• Data analysis focused on identifying consistent brain connectivity changes over time in response to metreleptin treatment.

Main Results:

• Metreleptin treatment led to significant increases in brain connectivity in the hypothalamus and posterior cingulate gyrus.
• A significant interaction between group (LD patients vs. controls) and time was observed in the hypothalamus.
• These findings were consistent with previous observations in an independent sample.

Conclusions:

• The study successfully reproduced increased brain connectivity in central nervous networks associated with appetite and metabolism in LD patients treated with metreleptin.
• Results support the role of leptin in modulating brain function related to metabolic and hedonic pathways.
• This research provides a foundation for further investigation into the central nervous system effects of metreleptin and leptin's broader metabolic functions.